Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.


TIDES 2017

Booth # 112
April 30 – May 3, 2017
Manchester Grand Hyatt
San Diego, CA

 PEGS 2017

Booth # 316
May 1 – 5, 2017
Seaport World Trade Center
Boston, MA